INSTITUTE OF CANCER RESEARCH - ROYAL CANCER HOSPITAL - United Kingdom 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:400-500
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:900-1000
Total Number of Projects:68
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Total Project Funding:400-500
Networking Rank (Reputation):800-900
Partner Constancy:400-500
Project Leadership Index:> 1000
Diversity Index:700-800
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Total Project Funding:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 19
As coordinator: 2
As participant: 9
Sole participant: 8
Coordinator / Participant Ratio: 0.22*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 2.000.000 3.998.125 2.756.193 1 1
2015 366.910 0 366.910 2
2014 462.566 2.499.123 2.961.689 2 1
2013 200.000 3.313.022 387.879 2 1
2012 209.033 6.000.000 709.033 1 1
2011 239.593 30.998.450 2.004.088 2 4
2010 0 10.499.999 90.716 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
KAROLINSKA INSTITUTE3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3
ACADEMISCH ZIEKENHUIS LEIDEN2
DANISH CANCER SOCIETY2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
INSTITUT GUSTAVE ROUSSY2
INSTITUT JULES BORDET2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
OSLO UNIVERSITETSSYKEHUS HF2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
STICHTING KATHOLIEKE UNIVERSITEIT2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITY OF GLASGOW2
AARHUS UNIVERSITETSHOSPITAL SKEJBY1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACZON1
AQUAMARIJN MICRO FILTRATION BV1
ASPER BIOTECH1
ASTRAZENECA UK LIMITED1
BIOCHEMICAL INSTITUTE FOR ENVIRONMENTAL CARCINOGENS PROF DR GERNOT GRIMMER FOUNDATION1
CANCER RESEARCH UK1
CELENTYX LIMITED1
CENTRO SANA SERVIZI SANITARI PRIVATI1
DANAFARBER CANCER INSTITUTE INC NON PROFIT CORP DFCI1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECANCERMEDICALSCIENCE1
EUROPEAN CANCER ORGANISATION1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
FINNISH INSTITUTE OF OCCUPATIONAL HEALTH1
FOCUSED ULTRASOUND FOUNDATION1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION INSTITUTO VALENCIANO DE ONCOLOGIA1
GENETICS RESEARCH INSTITUTE ONLUS ASSOCIAZIONE1
GENEXPLAIN1
GENOME RESEARCH1
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT CURIE1
INSTITUT NATIONAL DU CANCER1
INSTITUTO TUMORI GIOVANNI PAOLO II1
INSTYTUT FARMACEUTYCZNY1
INTERNATIONAL PREVENTION RESEARCH INSTITUTE SAS1
ISTITUTO EUROPEO DI ONCOLOGIA1
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI1
ISTITUTO ONCOLOGICO VENETO1
ISTITUTO ORTOPEDICO RIZZOLI1
JOHNS HOPKINS UNIVERSITY1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LEOCORDIA AB1
LEUKOCARE1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUNDS UNIVERSITET1
MAGYAR TUDOMANYOS AKADEMIA SZEGEDIBIOLOGIAI KUTATOKOZPONT1
NATIONAL HELLENIC RESEARCH FOUNDATION1
NATIONAL UNIVERSITY OF IRELAND GALWAY1
NETIX SKRZYPCZYNSKI KRZYSZTOFOWICZ SPOLKA JAWNA1
NOFER INSTITUTE OF OCCUPATIONAL MEDICINE1
ORBSEN THERAPEUTICS LIMITED1
ORSZAGOS KOZEGESZSEGUGYI KOZPONT1
ORSZAGOS ONKOLOGIAI INTEZET1
SKANE LANS LANDSTING1
SLOANKETTERING INSTITUTE FOR CANCER RESEARCH CORPORATION1
STICHTING ISALA KLINIEKEN1
THE CHRISTIE NHS FOUNDATION TRUST1
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAET BASEL1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITE DE GENEVE1
UNIVERSITEIT MAASTRICHT1
UNIVERSITEIT TWENTE1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF COPENHAGEN1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF LEICESTER1
UNIVERSITY OF WROCLAW1
UNIWERSYTET MIKOLAJA KOPERNIKA W TORUNIU1
VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA1
WEIZMANN INSTITUTE OF SCIENCE1

Constancy:

Total number of partners: 106
Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 97
Frequent / Rare Partner Ratio: 0.09

Project overview:

Start dateProjectacronymrolefundingpartners
2019-03-01Deciphering and predicting the evolution of cancer cell populations CANCEREVOcoordinator2.000.0001
2019-01-01Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone Metastasis FURTHERparticipant3.998.12510
2015-10-12Structural basis of Cullin-RING ligase regulation by the COP9 signalosome EMCOP9CRLcoordinator183.4551
2015-05-01RNA Polymerase III Rpc4/Rpc5 subcomplex and Selenocysteine tRNA transcription Human Rpc5coordinator183.4551
2014-10-01The use of genetic profiling to guide prostate cancer targeted screening and cancer care BARCODEparticipant2.499.1231
2014-05-01Studying Resistance to Cancer Therapeutics in Prostate Cancer RESICT-PCcoordinator231.2831
2014-04-04CHD1 Deletion: Implications to Outcome and Treatment in Prostate Cancer CDELPcoordinator231.2831
2013-10-01Transcribed-Ultraconserved Regions as novel biomarkers and therapeutic targets in liver cancer LIVERNCODEcoordinator100.0002
2013-06-01Targeting microRNAs for ColoRectal Cancer Therapy TAMIRCRTcoordinator100.0002
2013-03-01Decision-making within cells and differentiation entity therapies DECIDEparticipant3.313.0228
2012-09-01Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients CTCTRAPparticipant6.000.00012
2012-08-01Sequence of Mutational Events and Sub-clonal Architecture in Plasma Cell Myeloma ICRMYELOMAcoordinator209.0331
2011-06-01"ECNIS2: towards ECNIS Centre for Research and Education on Cancer, Environment and Food" ECNIS2participant1.000.00022
2011-06-01Molecular mechanisms of melanoma invasion Melanoma Invasioncoordinator209.5931
2011-03-01pARylation-mediated regulation of cancer pathways pARylomecoordinator30.0001
2011-02-01The DNA damage response and breast cancer DDRESPONSEparticipant6.000.0006
2011-01-01Systems Biology of Colorectal Cancer SYSCOLparticipant11.999.99611
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2010-07-01Breast Cancer Somatic Genetics Study BASISparticipant10.499.99915

Alias institution names:

  • INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL